Lung Cancer,SCLC (Small Cell Lung Cancer) Tarlatamab vs. Standard of Care in SCLC: Comparative Analysis of DelLphi-301 Apr 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Nivolumab Immunotherapy Before Surgery for NSCLC: Phase 2 NADIM Trial Apr 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) ORIENT-11 Phase 2 Trial Demonstrates Sintilimab in Non-squamous NSCLC Patients Apr 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Dabrafenib and Trametinib Combination Therapy for BRAF V600E Metastatic NSCLC: Apr 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Comparing Nivolumab and Ipilimumab to Chemotherapy in Advanced NSCLC: eNERGY Phase 2 Trial Apr 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Nivo+Ipi vs Continuation in Advanced NSCLC Apr 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Destiny-Lung02 Trial: Trastuzumab Deruxtecan for HER2-Mutated NSCLC Apr 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) INSIGHT 2 Trial: Tepotinib and Osimertinib Combination for MET-Amplified NSCLC Relapse Apr 20, 2023
